A 52-year-old woman from Mumbai presents with sudden onset dyspnea, syncope, and chest discomfort. She has a 3-week history of immobility following a femoral fracture. On examination: BP 80/50 mmHg, HR 128/min, RR 32/min, JVD prominent, right ventricular heave palpable. ECG shows sinus tachycardia with right axis deviation and T-wave inversion in V1–V3. Troponin I is elevated. Echocardiography reveals severe right ventricular dilatation with D-shaped septum and elevated RV pressure. CTPA confirms massive pulmonary embolism. Which pathological process in the pulmonary vasculature is responsible for the acute right ventricular failure observed in this patient?

Question

Accepted Answer

A. Acute increase in pulmonary vascular resistance due to mechanical obstruction and hypoxic vasoconstriction. ## Pathophysiology of Acute RV Failure in Massive PE ### Mechanism of Pulmonary Vascular Obstruction **Key Point:** Acute right ventricular failure in massive PE results from a sudden, severe increase in **pulmonary vascular resistance (PVR)**, not from infarction alone. The RV, which is a thin-walled, low-pressure chamber, cannot acutely compensate for this resistance. ### Two-Component Pathological Process ```mermaid flowchart TD A[Massive PE]:::outcome --> B[Mechanical obstruction
of pulmonary arteries]:::action A --> C[Hypoxia in non-embolized
lung zones]:::action B --> D[Increased PVR]:::outcome C --> E[Hypoxic pulmonary
vasoconstriction]:::action E --> D D --> F[Acute RV afterload
mismatch]:::urgent F --> G[RV dilatation &
D-shaped septum]:::urgent F --> H[Cardiogenic shock
& syncope]:::urgent ``` ### Pathological Components | Component | Mechanism | Contribution to PVR | |-----------|-----------|--------------------| | **Mechanical obstruction** | Thrombus physically blocks pulmonary artery branches | ~40–50% of PVR increase | | **Hypoxic vasoconstriction** | Alveolar hypoxia in non-perfused zones triggers arteriolar constriction | ~30–40% of PVR increase | | **Release of vasoactive mediators** | Serotonin, thromboxane A₂ from activated platelets | ~10–20% of PVR increase | | **Endothelial dysfunction** | Impaired nitric oxide production, increased endothelin | Amplifies vasoconstriction | **High-Yield:** The combination of mechanical + vasoconstrictive mechanisms creates a **multiplicative** (not additive) effect, explaining why massive PE causes such profound hemodynamic collapse. ### Why the RV Fails Acutely **Clinical Pearl:** The normal RV can tolerate chronic PVR increases (e.g., chronic pulmonary hypertension) through gradual hypertrophy. However, in acute massive PE: - PVR can increase **5–10 fold** within minutes - The RV has **no time** to hypertrophy - The thin RV wall cannot generate sufficient pressure - Result: **acute RV dilatation, septal shift (D-shaped), and shock** ### Histological Findings in Acute PE (without infarction) **Warning:** In massive PE, you typically see: - Thrombus within pulmonary arteries (mechanical obstruction) - Intact vessel walls (no fibrinoid necrosis unless there is vasculitis) - Alveolar hypoxia (no infarction if bronchial circulation intact) - Platelet aggregates and microthrombi in distal vessels This is **NOT** vasculitis (no immune complex deposition, no fibrinoid necrosis of vessel walls). **Mnemonic: SHOVE** — **S**udden PVR increase, **H**ypoxic vasoconstriction, **O**bstruction (mechanical), **V**asoactive mediators, **E**ndothelial dysfunction.

Answer

B. Atherosclerotic plaque rupture with superimposed thrombosis

Answer

C. Medial hypertrophy of pulmonary arteries from chronic hypoxia

Answer

D. Fibrinoid necrosis of pulmonary arterioles with immune complex deposition

Explanation

Pathophysiology of Acute RV Failure in Massive PE

Mechanism of Pulmonary Vascular Obstruction

Two-Component Pathological Process

Pathological Components

Why the RV Fails Acutely

Histological Findings in Acute PE (without infarction)

Practice similar questions

Join our NEET PG community

Component	Mechanism	Contribution to PVR
Mechanical obstruction	Thrombus physically blocks pulmonary artery branches	~40–50% of PVR increase
Hypoxic vasoconstriction	Alveolar hypoxia in non-perfused zones triggers arteriolar constriction	~30–40% of PVR increase
Release of vasoactive mediators	Serotonin, thromboxane A₂ from activated platelets	~10–20% of PVR increase
Endothelial dysfunction	Impaired nitric oxide production, increased endothelin	Amplifies vasoconstriction